English Spanish Chinese Russian German French Japanese Hindi Telugu Tamil

Anais de Pesquisa Clínica e Laboratorial

  • ISSN: 2386-5180
  • Índice h do diário: 17
  • Pontuação de citação de diário: 6.26
  • Fator de impacto do periódico: 5.31
Indexado em
  • Genamics JournalSeek
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
Veja mais
Compartilhe esta página

Abstrato

Genome-Wide DNA Methylation Profiling Uncovers Competitor Biomarkers and Plausible Atomic System of Metabolic Disorder

Su-jeong park*

Answering the worldwide need to give proof on the effect of interruptions and their moderation, the COVID-19 and Cancer Global Modeling Consortium (CCGMC) was laid out in May 2020. The CCGMC plans to orchestrate pertinent proof on COVID-19 and disease and arrange demonstrating stages that illuminate decision-production in malignant growth control. The CCGMC has created three interrelated work streams, measuring the effect of COVID-19 on malignant growth results, screening and analysis, and disease risk. The accentuation is on creating framework that will permit scattering of persistently refreshed short-and long haul projections of malignant growth significant results. There is a significant spotlight on assessing likely prioritization and recuperation methodologies during and following the serious social and wellbeing administrations interruptions experienced around the world.